An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

University of Science and Technology of China (USTC)

Status: Not yet enrolling

Conditions: Parkinson's Disease

Treatments: Other: Observational

Study type: Observational

Funder types: Other

Identifiers

NCT07279844

RGL-193-LTS

Details and patient eligibility

About

To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

Full description

An open-label, observational, long-term follow-up study evaluating the safety and efficacy of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

Enrollment: 6 estimated patients

Sex: All

Ages: 45 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Subjects who have previously participated in RGL-193-related studies and have received RGL-193 treatment；
2. Those who voluntarily participate in this trial and sign a written informed consent form -

Exclusion criteria

None

-

Trial design

6 participants in 1 patient group

Subjects who have previously participated in RGL-193-related studies and have received RGL-193 treat

Treatment:

Other: Observational